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In 2002, the National Institutes of Health sponsored a meeting concerning methodological
challenges of research in psychosocial interventions in Autism Spectrum Disorders. This paper
provides a summary of the presentations and the discussions that occurred during this
meeting. Recommendations to federal and private agencies included the need for randomized
clinical trials of comprehensive interventions for autism as the highest, but not the sole
priority. Ongoing working groups were proposed to address psychosocial interventions with a
focus on relevant statistics, standardized documentation and methods of diagnosis, develop-
ment of outcome measures, establishment of standards in research; and the need for
innovative treatment designs, including application of designs from other research areas to the
study of interventions in ASD.
In September 2002, a National Institutes of
Health-sponsored meeting concerning methodologi-
cal challenges of research in psychosocial interven-
tions in autism took place over a day and a half.
The purpose of the meeting was to convene a group
of investigators and stakeholders to inform the
National Institutes of Health and other relevant
government agencies about the current state of the
science with regard to (a) psychosocial, behavioral
and educational interventions for children with
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autistic spectrum disorders (ASD), (b) barriers to
progress in the field, and (c) potential strategies for
overcoming those barriers. Presentations and discus-
sion by parent advocates, professional consumers,
and investigators addressed these issues from various
perspectives.
The conference began with participants provid-
ing brief presentations concerning the state of the
science in five areas. Each presentation was followed
by comments by one or two discussion facilitators
who then led the discussion in that area. The five
areas consisted of (1) a general update on how far we
have come and where we need to go; (2) recruitment
challenges and solutions; (3) measurement of out-
come; (4) challenges in methodology; and (5) strat-
egies about how to move from the lab to the
community and from efficacy to effectiveness. On
the second day of the meeting, discussion focused on
strategies for facilitating collaboration, increasing the
quality of research, partnering with families and
communities, and identifying ways in which govern-
mental support could be used to facilitate progress.
WHAT ARE UNIQUE ISSUES IN
CONSIDERING THE PSYCHOSOCIAL
TREATMENTS OF ASD?
Although the purpose of the meeting was to
address issues specifically related to psychosocial
interventions for individuals with Autism Spectrum
Disorders (ASD), one of the secondary goals was to
apply knowledge from other types of treatment
research to our field. Thus, many of the ideas
discussed here are relevant to other disorders. Never-
theless, there are a number of features of ASD that are
unique or at least, that differ from many other
psychiatric disorders beginning in childhood. There
is tremendous variability in ASD, in part because the
disorders are defined by a pattern of behaviors that
are quite different from each other (e.g., very basic
social behaviors, unusual motor patterns, specific
language characteristics) and in part, because of the
frequent, but not universal association of ASD with
expressive and receptive language delays and mental
retardation. This variability means that a comprehen-
sive assessment is a critical part of treatment in ASD
in order to define the characteristics and ability levels,
as well as the needs of individuals (Howlin, 1998).
The deficits in very basic skills that are usually
present in typical infants and toddlers that
define ASD (Klin, Volkmar, & Sparrow, 1992), the
pervasiveness of these deficits across contexts, and the
very early onset noted in most children also affect the
design and selection of treatments, in that interven-
tions are needed that are as comprehensive as the
disorders are pervasive, and that begin as early as the
disorders are recognized. Thus, the age suggested for
optimum intervention to begin for autism is far
younger than for children with Attention Deficit
Hyperactivity Disorder, anxiety or depression. More-
over, research suggests that early intervention can
result in significant improvements for some children
with autism, though for how many children and for
how much gain has varied considerably across
studies. (Anderson et al., 1987; Birnbrauer, 1997;
Dawson & Osterling, 1997; Fenska, Krantz, &
McClannahan, 1985; Green et al., 2002; Harris et al.,
1991; Lovaas, 1987; McEachin, Smith, & Lovaas,
1993; Rogers, 1998; Sheinkopf & Siegal, 1998).
Traditional 1 h a week treatments for language or
social skills or behavior used in the US mental health
system are rarely sufficient to produce generalizable
improvements in core areas of ASD (Howlin, 1998;
Wetherby, Schuler, & Prizant, 1997). On the other
hand, comprehensive treatments are extremely expen-
sive to carry out and require large numbers of highly
trained staff and infrastructures that greatly limit who
can study the effects of intervention on groups of
children. Although other disorders also affect learn-
ing and social opportunities, the degree to which the
deficits associated with autism affect and are affected
by other areas of development is generally greater,
which also contributes to the need for comprehensive
treatments (Lord & Bailey, 2002).
There is currently no medical or biological
treatment of the core features of ASD, though there
are medications that ameliorate certain aspects of
behavior or mood, such as activity level (Aman,
1996) or irritability (Arnold et al., 2003). Thus, the
primary source of intervention for most children is
through their families and through the educational
system. The majority of research papers about
treatment of individuals with ASD is from a behav-
ioral perspective, but there are a number of widely-
used programs with alternative models, including the
TEACCH program (Schopler, Mesibov, Shigley, &
Bashford, 1984) that often include both developmen-
tal and behavioral components (Harris & Weiss,
1998). In general, there is a wide gap both between
studies of very specific techniques (such as timing in
prompting conversational skills or replacement of a
repetitive behavior with a more appropriate action
(Durand & Carr, 1987) and outcomes that range
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from very specific (e.g., asking a certain kind of
question) to very general (e.g., full inclusion in a
regular school program; looking indistinguishable
from normal). None of these issues is completely
unique to ASD, but, taken together, they mean that
research designs about treatments must be
approached with care and creativity.
Below, the presentations and discussions are
summarized briefly within the headings of themeeting.
State of the Art Evidence-based Treatment: How Far
have We Come and How Far do We Need to Go?
A great deal of knowledge about psychosocial
treatments in ASD exists. Nevertheless, this knowl-
edge represents only the beginning of understanding
why and how best to design interventions for
individuals with ASD. Providing intervention for
individuals with autism, most often across the life-
span, is an expensive proposition for most children
and adults. Recent reports, based on Lovaas’ original
study (1987), suggested that improvements produced
by early intervention in Autistic Spectrum Disorder
may result in cost-saving to society of nearly $200,000
by the time an individual reaches age 22 years and a
million dollars by the time an individual was age
55 years (Columbia Pacific Consulting, 1999; Jacob-
son, Mulick & Green, 1998). Cost effectiveness of
treatment has not yet been broken down by individ-
ual differences in response to various interventions.
Most group-design research in autism has con-
cerned comprehensive curricula. Consequently, it has
been difficult to identify the effects of components of
these programs (see Dawson & Osterling, 1997;
Kasari, 2002; National Research Council, 2001;
Rogers, 1999) or the underlying mechanisms for
change. Research in developmental psychology sug-
gests that sensitivity to sequences of typical develop-
ment and to individual differences, including
transactions (e.g., between the individual with ASD
and parents or family members or teachers, or
between higher level organizational factors such as
school systems and families) is important (Dunst,
1999; Rogers, Hall, Osaki, Reaven, & Herbison,
2001; Schuler, Prizant & Wetherby, 1997).
Many single-subject designs have already indi-
cated that specific interventions are associated with
learning in ASD. A number of different models of
interventions have shown significant improvements in
a subset of children, but rarely have they resulted in
complete amelioration of social difficulties (see Daw-
son & Osterling, 1997; National Research Council,
2001; Rogers, 1999). The question then becomes
whether a particular treatment results in more
improvement than another treatment. Once this is
demonstrated, one might ask (a) why this is the case,
(b) how much more improvement does it offer, (c)
what are the consequences of this difference, (d) with
whom is it evident, and (e) how long does this effect
last and how generalizable is it? A lack of well-
developed theories about how treatment effects are
mediated has left the field with some sense of
predictors of outcome, but little knowledge about
how and why improvements come about.
For example, in most longitudinal studies, early
IQ scores have played a strong role in predicting
independence and achievement (Howlin, Mawhood,
& Rutter, 2000; Venter, Lord, & Schopler, 1992).
Early social-cognitive functioning has also predicted
language growth in autism (Sigman et al., 1999).
Longitudinal and intervention studies have shown
that individuals who are more mildly affected by
autism, defined by severity of symptoms (e.g., those
diagnosed with PDD-NOS versus autism) and higher
intellectual level and more typical early social-cogni-
tive functioning (Bartak & Rutter, 1973; Sheinkopf &
Siegel, 1998; Smith, Groen, & Wynn, 2000b; Yirmiya
& Sigman, 1991) show better outcomes.
However, such conclusions, for example, that
initial IQ score and severity of autism are predictors
of response to treatment, are based on studies of
development, often within a treatment group. These
studies do not necessarily inform us about response
to treatment, but tell us about the relationship
between child characteristics and developmental tra-
jectories. To understand response to treatment, one
needs to know if a difference between treatment
groups varies as a function of pre-treatment charac-
teristics, that is, is there a statistical interaction
between the characteristics and treatment? (i.e., do
children with ASD and better verbal skills show
greater improvements than we would expect, given
their stronger language skills, when they receive a
particular treatment than if they had no treatment,
compared to children with weaker verbal skills?)
In psychopharmacological studies of children
with autism (Owley et al., 2001), placebo effects were
quite strong. They demonstrate the important effects
of study enrollment and the perception of receiving a
potentially effective treatment. Yet there are only
three published studies that have used a randomized
control design to determine intervention outcome in
response to psychosocial treatments (Drew et al.,
2002; Jocelyn, Casiro, Beattie, Bow, & Kneisz, 1998;
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Smith et al., 2000a, b). In the Smith and colleagues’
study of a comprehensive program of the Lovaas
treatment model, at follow-up, the intensive treat-
ment group had a statistically significant advantage
over a parent-training group in IQ and visual-spatial
skills, but not adaptive behavior or language. Within
both groups, there were large individual differences in
response. Though the study was a randomized group
experiment, it also looked for differences between
‘‘best-outcome’’ children and ‘‘non-best-outcome’’
children. Interpreting these differences as ‘‘predictors
of treatment response’’ requires the assumption that
the only reason for the best-outcome results is due to
the treatment, which may not have been the case.
As discussed later, this lack of information has
led some investigators to call for Randomized Con-
trolled Trials (RCTs) with sufficient numbers of
participants that moderator variables, such as envi-
ronmental features, child variables, and family fac-
tors, can be studied. Such trials would deliberately
manipulate intensity and address a broader range of
outcomes than has typically been studied (see below).
To adequately address mediator and/or moderator
variables, there need to be at least 10 participants per
variable, which would require trials coordinated
across a number of sites, as have occurred in other
national cross-site studies, such as treatment trials for
cancer, depression, and ADHD.
In much of medicine, the view of a single RCT as
providing a completely decisive answer is now being
replaced by one in which a study is seen as contrib-
uting to a larger body of evidence, by meeting
standards that allow inclusion in a systematic review
(McLeod & Weisz, 2004). All treatment studies
should be designed in such a way that they can
contribute to a greater program of knowledge accu-
mulation beyond whether a particular treatment is
more effective than another treatment in a particular
sample. This expectation implies attention to even-
tual replicability, including treatment manuals, stan-
dard subject selection and measures, and some links
between theory and predictions in all studies. Meth-
odologies such as partial factorial designs may be
particularly relevant to ASD.
There was much discussion regarding the need for
well-monitored control groups and the possibility that
‘‘no treatment’’ controls may be less appropriate than
an alternative treatment group because of the known
effects of positive expectations and hope on the
examiners, parents, and the children. Nevertheless,
very little is known about the effects of intervention on
parents, or about the accessibility and feasibility,
particularly the affordability, of the most well docu-
mented models in public schools or public health
settings. A minority considered the continued use of
no treatment control groups justified because such a
design could detect whether new treatments slow down
or had negative effects on behavior or development. A
further complexity, however, is that a ‘‘no treatment’’
control raises ethical concerns, particularly if the study
period is lengthy, as it typically has been in early
intervention studies. In addition, a considerable liter-
ature already exists in autism (though primarily not
formal RCTs), showing that some treatment is better
than treatment with no evidence of negative effects of
treatment (see Dawson & Osterling, 1997; National
Research Council, 2001; Rogers, 1999), at least in
early childhood interventions.
Many single-subject multiple baseline designs in
older children and adults have also shown positive
effects of treatment, though single subject designs
also do not necessarily indicate if development was
‘‘slowed’’ by treatment. In small studies, there is the
need to consider case-wide influence statistics to
ensure that effects were not due to a small number of
unusual individuals. Smaller studies including single
subject designs and detailed qualitative analyses most
appropriately introduce innovative treatments and
may raise important questions about factors that
maintain gains made in response to the more com-
prehensive interventions.
Reviews of 48 different journals in research
carried out in the 1990s revealed 835 articles about
psychosocial and educational intervention, which
included 185 single-subject designs. However, studies
that included children with autism were relatively
rare, accounting for only about 10% of the partic-
ipants. As of 2002, a total of only 30 papers
concerned children under age 6 with ASD. Many of
the practices most strongly supported by published
papers, for example, positive behavioral supports,
have not been studied specifically for children with
autism, though there is reason to believe that these
strategies may be effective (Horner, Carr, Strain,
Todd & Reed, 2002). The most common designs are
multiple baseline studies in which a treatment is
introduced after varying lengths of baseline assess-
ment. Topics addressed in these studies included
individualized interventions, manipulation of conse-
quences, use of naturalistic teaching approaches,
peer-mediated intervention, use of prompting proce-
dures, functional assessment, a range of measures
involving changes in environment (including physical
space), and the development of many different skills.
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The largest collections of studies about children
with autism to date concern reduction of behavior
problems as communication increases, peer-media-
tion and the use of prompting procedures.
One single-subject methodology, the reversal
design, involves systematically introducing and with-
drawing a treatment two or more times to test the
effects of the treatment on the occurrence of a
particular behavior. Reversal designs are useful for
examining how to modify already acquired behaviors
that vary primarily in frequency. However, because
they require repeatedly withdrawing treatment, they
are usually inappropriate for studying how to develop
new skills. They are also inappropriate when teaching
developmentally important skills in part because, if
the skill is well-chosen, then typical environmental
reinforcers will support the skill and withdrawal of
the study intervention would not necessarily with-
draw all the reinforcement. For this reason, although
reversal designs are easily interpreted, they have had
limited value for many of the developmental outcome
goals addressed in autism.
Single subject reversal trials are often treated as
multiple baseline designs when only the first with-
drawal of treatment is interpreted. However, such
designs demonstrate obvious effects, only when
targeted behaviors change abruptly with the onset
of the treatment, something that is rare in children
with autism when developmentally important depen-
dent variables are used. On the other hand, single-
subject design approaches have paid more attention
to generalization, maintenance, and social validity
than other approaches in the field of autism (see
National Research Council, 2001). Single-subject
designs continue to offer strengths as initial tests of
innovative treatment when individual differences and
general effects or major changes in development are
not an issue. We know relatively little about gener-
alization and maintenance of the effects of compre-
hensive programs, though single-subject designs have
increasingly included measurement of these aspects of
change (Goldstein, 2002; McConnell, 2002). More
recently, some studies of comprehensive behavioral
interventions have discussed short-term changes as
well as more general outcomes (Eikeseth, Smith, Jahr,
& Eldevik, 2002).
A number of discussion points were raised.
Because almost all studies of ASD treatments used
behavioral techniques (Lovaas, 1987) with some
attention to developmental sequences and communi-
cative intent (Ozonoff & Cathcart, 1998; Wetherby
et al., 1997), the content of the interventions and the
fidelity and intensity with which they were carried out
often varied more than the methods used. Differences
in effectiveness, therefore, may have been due to
many factors in addition to or besides the targeted
treatment comparison. Although clinical observation
suggests that several approaches (e.g., developmental,
behavioral, structured teaching) are often used
together in practice in ASD, the most effective ways
to integrate developmental and other approaches
with behavioral methods has not yet been tested
systematically. Treatments vary as to whether they
are addressing a specific behavior or symptom, or
whether they address the ‘‘syndrome’’ of autism. In
recent collaborative psychopharmacological clinical
trials, investigators agreed to focus interventions on
symptoms such as irritability or aggression and not to
‘‘oversell’’ treatments as cures for the syndrome of
autism (Arnold et al., 2000; Scahill & Lord, 2004).
Intervention studies using the Applied Behavior
Analysis (ABA) or Early Intensive Behavior Inter-
vention (EIBI) have not generally specified what
measures are expected to change (e.g., core symptoms
of autism, degree of cognitive impairment, functional
use of language) nor have they followed standard
practices in clinical trials, such as indicating the effect
size that would be considered a significant change.
Recruitment
Discussion of recruitment dealt generally with
how to insure that results from individual studies
could be interpreted in terms of more general
populations. Three levels of challenges were outlined:
(1) How to identify children and adults to participate
in autism studies, (2) How to arrange for participa-
tion in a way that affects families positively and (3)
How to maintain good community relations. Differ-
ent motivations for families to participate in research
were identified including (a) access to direct, better,
or free services; (b) helping the ‘‘greater good,’’ (c)
financial incentives, (d) and desperation (in the case
of families seeking any new treatment when little else
has been helpful).
Various recruitment strategies were discussed. A
number of recruitment options were proposed,
including (1) recruiting only children with existing
diagnoses from established diagnostic centers, (2)
recruiting children at risk or suspected of ASD and
providing diagnoses through the research—a strategy
that can become very expensive, but results in more
standardized diagnoses or (3) establishing a feeder
diagnostic clinic from which to recruit. The pros and
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cons to the alternatives were discussed. Large studies
demand a focused, dedicated recruitment effort. This
cannot be done by mail; personal approaches are
necessary. Recruitment aspects of intervention
research must be a priority in autism research,
meriting a dedicated financial investment. Project
coordinators/recruiters and principal investigators
must be willing to take initiative in finding partici-
pants, with one person or one arm of a project
‘‘responsible’’ for recruitment.
Specific recommendations for responsible inclu-
sion of participants with autism were made, including
offering written reports of assessments, flexibility in
scheduling, providing clinical interpretation of diag-
nostic and developmental results, and building into
research planning family support, access to expert
consultation, or help in identifying quality resources.
Families must perceive all treatment options as
approaches that are strongly recommended by the
investigators. It is difficult to keep families in a
treatment-as-usual group and impossible to separate
the effects of hope, enthusiasm, confidence and often
training of the interveners from specific aspects of the
treatment (see Eikeseth, Smith, Jahr & Eldevik,
2002), if deliberate plans are not made to take these
factors into account.
Although in recent years, the bulk of parent
advocacy for research has supported biomedical
studies, there are groups of parents who are strongly
committed to addressing the need for psychosocial
and behavioral research. From a parent’s perspective,
the possibility of being assigned to a placebo control
group rather than treatment is a concern. Time
commitments, needs for excessive documentation,
and questions about the family’s role in experimental
research (‘‘being a guinea pig’’) are also of impor-
tance. Researchers were urged to recognize that most
individuals with autism will be receiving multiple
interventions and this must be taken into account
within research designs.
Recommendations beyond having a focused
recruitment plan included having experienced clini-
cians on research teams and promoting community
awareness of early signs of autism, both through
personal contact with referral sources such as pedia-
tricians, general practitioners, and local practitioners
including speech and language pathologists, audiolo-
gists or occupational therapists, and through collab-
oration with existing early intervention settings. The
ethical aspects of families’ needs for access to services
and clinical information must also be considered.
Another practical recommendation was that studies
keep standard data from screening contacts so that
records are kept about which individuals participated
and did not participate in the research. It was noted
that, in RCTs for a complex disorder such as autism,
there should be as much attention paid to the control
group as to the experimental treatment group. Fur-
thermore, it is clear that most children and families
who participate in treatment research do not represent
the general population. Information about which
families took part in different studies and which did
not (and why or why not) could provide invaluable
information concerning the eventual potential effec-
tiveness of a treatment for ASD.
Outcome Measures
Outcome measures can be grouped according to
whether they are measured close in time to the
intervention or in longer-term follow-up, whether
they are near or distant to the treatment in terms of
the conceptualization, and to what degree, inferences
about specific effects of a treatment can be drawn
(Charman & Howlin, 2003; Drew et al., 2002). A
distinction can be made between skills directly taught
by the treatment and general measures of develop-
ment likely to be affected by these skills. One of the
inherent ‘‘trade-offs,’’ is that outcomes that are close
to interventions in theoretical conceptualization may
be less practically meaningful for families and clini-
cians. For example, in autism, improvements in
spontaneous imitation or emotional responsiveness
may be easier to link to theory, but less appealing to
parents as measurements of treatment success than
full-inclusion or ‘‘normal appearance’’.
Ideally, the anticipated relationships between
general areas of development and specific behaviors
can be identified. For example, for an intervention
aimed at improving children’s joint attention, one
might predict, as outcomes, that a child would (1)
initiate more joint attention and respond more
consistently to others during attentional acts, (2)
produce more language in coordination with joint
attention, and (3) show general increases in social
interest and initiation. Similarly, in a study examining
improvement in communication through use of a
visual system (Picture Exchange Communication
System or PECS: Bondy & Frost, 1994), one might
first look at (1) a child’s ability to learn to understand
and use the system in a teaching situation, (2) then
the extent to which the child uses the system in
comprehension throughout a number of circum-
stances and whether the child initiates using the
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system across contexts and (3) then whether there
were general changes in the child’s social interaction
or language level.
A recommendation was made that research
designs should initially focus on specific target behav-
iors and then study the relationship between specific
targets and theoretically based predictions of changes
inmore general development. Studies targeting general
changes (e.g. ability to learn in a regular classroom) are
likely to be uninterpretable without evidence of the
links between changes in specific targets and more
general outcome. Group differences in general out-
comes in a randomized group experiment can be
interpreted as a treatment effect, but themechanism by
which the treatment had an effect on these outcomes is
uninterpretable without information about more spe-
cific changes. Longitudinal studies may also help us
understand the relationship between different levels of
change that are targeted. For example, is it necessary
that a child with ASD improve in joint attention in
order to show improvements in language in response to
a particular intervention?
Given variation in baseline levels of earlier-
emerging skills, it seems unlikely that any treatment
will work comparably for all children or adults with
ASD. Effects of both chronological age and devel-
opmental levels in various areas are probably not
linear, and the magnitude of effects may vary
according to where in a developmental trajectory
teaching of a skill begins. For example, teaching a
pre-verbal child 5 words may be different than
teaching 5 more words to a child with 5 words
already. Eventually, when studies of psychosocial
interventions in autism address broader populations,
the need to control sources of variation such as
family variables, level of parents’ IQ scores, and
ethnicity will be crucial. As noted earlier, specific
relations between treatment characteristics and indi-
vidual differences (of both children and families) need
to be considered. This will require complex studies
with large samples.
Discussants raised the importance of attending
to child behaviors in ASD that elicit or enable adult
use of facilitating actions. These child behaviors
include ‘‘pivotal responses’’ that provide a child with
important ways to learn from others (Koegel, Koegel,
& McNerney, 2001) and those eliciting ‘‘boot-strap-
ping operations,’’ that is, that result in positive
responses from other people that may lead to learning
of other behaviors (Shatz & Ebeling, 1991). The need
to attend to changes in developmental level, such as
age equivalents, or acquisition of specific skills (as
opposed to changes in level of impairment such as IQ
scores) was raised. However, when age equivalents
are compared across a variety of measures, the
limitations of this strategy must be acknowledged a
priori (Mervis & Robinson, 1999).
In addition, not all children with ASD benefit
from treatments addressing the same goals. One
research design has been to match individuals with
ASD in pairs on certain variables and then randomize
them into treatment groups (Van Bourgondien,
Reichle, Campbell, & Mesibov, 1998) from the pairs.
Another alternative is to compare actual to expected
progress within different domains (Rogers, 1999).
Eventually, designs that compare different kinds of
treatment will provide important options in this
regard. An example was presented from a study by
Connie Kasari (in preparation), in which treatments
emphasizing symbolic play versus joint attention
were compared in terms of their effects on joint
attention behaviors and a number of different types
of play in both structured and less-structured settings.
Several important factors in selecting outcome
measures in ASD were identified. As in standard
protocols for clinical trials, outcome measures must
be decided in advance; investigators should prioritize
which measures will and will not respond to treat-
ment (Aman et al., 2004). This has not typically
occurred in comprehensive autism treatments.
Foremost was attention to the need for measures
that assess generalization and measures that can be
used across activities, interaction styles, and task
demands. Thus, outcomes need to match the require-
ments of research design without sacrificing the social
importance of variables. Measures of social validity
relevant to autism from both parent and teacher
measures were discussed. One example was the recent
use by Research Units on Pediatric Psychopharma-
cology Autism Network (Arnold et al, 2003) of
changes in parent-nominated symptoms. Another
example was the use of teacher-rating scales. The
importance of using measures that are responsive to
change was reiterated. There has recently been much
interest in using the Autism Diagnostic Observation
Schedule (ADOS – Lord, Rutter, DiLavore & Risi,
1999) and the Childhood Autism Rating Scale
(CARS – Schopler, Reichler & Renner, 1988) as
treatment outcome measures. Broadening the ranges
of scores in the instruments might make both more
useful in this regard by extending the range of codes
beyond 0–2 or 1–5 (for the ADOS and CARS,
respectively). However, in at least one recent study,
placebo effects were of more concern than sensitivity
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to change (Owley et al., 2001). Acknowledgment of
practice effects, which have been measured on small
samples, is also important (Lord et al., 1999). Inte-
grating the use of multiple instruments, both general
and specific, within a domain, such as designing
communication samples collected during the ADOS
or other observations, and employing broader mea-
sures such as the Children’s Global Index (CGI) were
all suggestions (Scahill & Lord, 2004).
Methodological Challenges
The discussion of methodological challenges
included a number of different perspectives in deter-
mining appropriate methodology in treatment trials.
It was recognized that Randomized Clinical Trials
(RCTs) have made a critical contribution to medicine
and clinical practice (Medical Research Council
Health Services and Public Health Research Board,
2000). RCTs protect the public from deliberate false
claims and exploitation and from well-intentioned
and sincerely-believed views that may nonetheless be
false. The use of RCTs enable more efficacious
treatments to be shown as better than less efficacious
treatments. On the other hand, RCTs, while crucial,
do not by themselves form a complete and coherent
program of treatment development and evaluation.
Without sufficient sample size and attention to
possible mediating factors, treatment by child inter-
actions cannot be assessed. RCTs will not necessarily
indicate the trajectory of change or time. Single-blind
studies that follow conventional guidelines may be
nearly impossible, even though historically, the less
rigorous that randomized control trials are, the
stronger the findings, so awareness of these trends is
critical.
In general, neither the ‘‘autism community’’ nor
most educational researchers, have emphasized RCT
standards for design, implementation and reporting
of studies. In addition, because many parents of
children with autism are well-informed about differ-
ent treatments, conducting a highly controlled ran-
domized clinical trial is difficult due to treatment
switching, and ‘‘contamination,’’ as parents seek out
treatments that they perceive as most useful for their
children (and as clinicians and educators include
aspects of these approaches in their interventions).
When a new treatment is designed and assessed and
then is changed after alternative treatments have been
compared, assessing the effect of the original treat-
ment becomes complicated. Yet, clinical and educa-
tional practice is often changed as interventions are
put into play. Comparisons of a particular interven-
tion to treatment-as-usual at one point in time are not
necessarily the same as comparisons of that same
treatment a year later to treatment-as-usual (i.e., it is
likely both the experimental treatment and the
treatment-as-usual have changed).
Ideally, RCTs would allow comparisons of
treatments with minimal differences so that the active
elements linked to effectiveness could be identified.
However, in many cases, such an approach would be
viewed as not sufficiently informative to merit large-
scale support. Currently, most treatment studies in
ASD are carried out with very limited funding
compared to what would be needed to conduct an
informative RCT. Only a few treatments can be
tested at any one time in a standard, large RCT.
While there was general, though not universal,
opinion that a standard ‘‘control’’ treatment ought
to be selected and new treatments be compared to it,
there was much disagreement as to what this stan-
dard treatment ought to be. Interventions based on
Applied Behavior Analysis (ABA), such as the
Lovaas model (Lovaas, 1987; Smith et al., 2000a),
have received the most empirical study using group
designs and so might be considered the appropriate
treatment for comparison. An alternative would be to
use a less expensive treatment that is feasible in public
school programs, such as TEACCH (Ozonoff &
Cathcart, 1998; Schopler et al., 1984). Consensus
about such an approach was not achieved in this
meeting.
Across-site replication by independent research
teams was considered the most useful source of
information about the efficacy of treatment in autism.
Study designs should allow pooled data, whether the
initial methodology is single-subject or RCT. The
need for researchers to use standard evaluation tools,
as well as to develop unique assessments for their own
projects, and the need for evaluators to have had
similar training and to pool research findings were
stressed. With children with autism, experimenter and
test differences at baseline and outcome assessments
(e.g., Koegel et al., 1997) may yield differences com-
parable in size to likely intervention effects. For
example, several studies have shown marked increases
in IQ moving from the Bayley Scales (Bayley, 1993) to
performance tests, especially the Merrill–Palmer
Scales (Stutsman, 1931), (Lord, 1991; Schopler,
Reichler, Devellis, & Daly, 1980). In addition, devel-
opmental change over time in ASD may often exceed
the effects of interventions. A number of implications
of these complexities were noted. Maintaining the
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blindness and skill of testers becomes important, and
is quite difficult to achieve without extensive planning.
Finally, the need for further information regard-
ing subgroups of children, such as high-functioning
children who are speaking spontaneously by age 2 or
3 years, children who use only minimal spoken
language by later preschool, and older children and
adults with behavior problems, should not be
neglected in a focus on broad-based early interven-
tion. For example, creating interventions that differ,
not necessarily on the first treatment, but on what
happens if the first treatment is effective or ineffective
may be one approach. Such strategies might be able
to incorporate family preference and clinician pref-
erence within a model that could be replicated across
individuals.
From the Lab to the Community
Despite complexities, many recent reviews (Daw-
son & Osterling, 1997; Rogers, 1999) have emphasized
how much useful information is available about how
to teach and work with children and adults with
autism. There is a great deal of information has been
generated by researchers that can be helpful to
classroom teachers about the technology needed to
help students with autism master many discrete skills
from tying their shoes to toilet training, reading
words, making initial social approaches, and carrying
out basic vocational tasks (National Research Coun-
cil, 2001). There is a body of knowledge on assessing
the functions of maladaptive behavior and helping
students learn more adaptive ways to solve problems,
and much information regarding the role of commu-
nication in behavior management (Horner et al.,
2002). However, there are also significant areas of
‘‘uncharted territory,’’ including very basic aspects of
treatment such as the number of hours of intervention
needed to accomplish major changes (see Sheinkopf &
Siegel, 1998) and whether common treatments such as
the Developmental, Individual-Difference, Relation-
ship-BasedModel (DIR) (Wieder & Greenspan, 2003)
or TEACCH (Schopler et al., 1984) or the Denver
model (Rogers et al., 2001) are equally strong as
various models based on Applied Behavior Analysis
in supporting children’s social and cognitive develop-
ment. Many of the comprehensive programs
described in the Educating Children with Autism
book (National Research Council, 2001) have detailed
curricula that are not yet generally available to the
public. The need for manualization of treatment is
crucial to dissemination.
The need to recruit underrepresented popula-
tions, such as those living in rural areas, ethnic
minorities, and non-English speaking children, the
potential of internet capability to reach a broad
audience, and the force of advocacy organizations to
support research about psychosocial interventions
was also highlighted. Almost all of the current
psychosocial interventions in autism have been built
on studies with white middle class populations. There
has been little attempt to test the relevancy of
different treatments to other ethnic or socioeconomic
groups. Almost all of the intervention programs are
university-based.
Another issue is how to measure the effects of
the multiple other treatments in which families are
involved, because of the potential statistical interac-
tions with the within-project treatment. There have
been relatively few attempts to investigate how these
strategies might apply in public school programs for
children whose families have fewer resources or less
education (Rogers, Lewis, & Reis, 1987). Many rural
and inner city children in the United States receive
minimal interventions of any type. Consequently,
these children may be the most likely to change as the
result of a particular intervention, though they add
other complexities. The advantages of parental
involvement in research planning in terms of com-
munication, developing measures of meaningful out-
comes, and helping to identify some immediate
benefits for all who participate were emphasized.
The Canadian Autism Intervention Research
Network was described (CAIRN: Canadian Autism
Intervention Research Network, 2001; see also
www.cairn-site.com). This national multi-disciplinary
network involves scientists, clinicians, parents, and
policy makers. It was proposed that one of the
reasons that evidence-based treatments are often not
implemented in community settings is that parents
and policy makers do not see the relevance of the
research. If families and politicians and administra-
tors are involved in the development of a research
agenda from the beginning, more effective treatments
may become available as a matter of policy. Focus
groups including parents, teachers, therapists, and
scientists emphasized the need for evaluation of
intensive multi-disciplinary interventions that use
existing resources and focus on clinically-relevant
outcomes for individuals with ASD. Findings from
research need to be tied explicitly to training and
advocacy. The importance of transportability and
dissemination of techniques was emphasized. A
working group in the UK also produced a report
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about the design of autism treatment studies. The
earlier discussion in this paper on ‘‘levels of infer-
ence’’ was based on this document (Charman &
Howlin, 2003; Drew et al., 2002).
In a recent program run by the National Early
Childhood Teacher Assistance System (NECTAS) in
the United States, state representatives identified
several of their greatest concerns as follows: (a) the
increasing number of children diagnosed as having
Autistic Spectrum Disorder (ASD), (b) the lack of
availability of diagnostic centers or experts, and (c)
the increasing number of children identified at
younger ages (with some local service providers
having little experience working with young children
with ASD). Inequities in access to expertise,
resources, and appropriate services occur across and
within states. Questions continue to emerge as to
whether individual communities should endorse and
fund one model, an array of models, or work
primarily to embed effective practices into existing
programs. While selecting from many resources
implies a wealth of opportunities to individualize,
one concern is that many providers engage in eclectic
practices for which there has not been systematic
planning or research.
Few states require special certification or
endorsement to work with children with autism.
Teachers’ and professionals’ knowledge of interven-
tion research in autism is often minimal. Though
some have begun to use the Educating Children with
Autism report from the National Research Council
(National Research Council, 2001), the book has not
yet been disseminated as widely as possible in a form
useful to practitioners or parents.
Equitable allocation of resources has not been
based on treatment research; instead resources have
often been determined by parents and professionals’
hope for the most dramatic gains. There are vast
inequities in per pupil expenditures based on the
success or failure of litigation by small numbers of
families. Challenges for the states include the need (a)
to maximize use of the existing public resources
(federal, state, and local); (b) to access and under-
stand multiple approaches across the state; (c) to
extend the use of Medicaid Waivers to fund services
such as in-home treatment and personal care services;
and (d) to define medical necessity in a way that
includes symptoms associated with ASD. Suggested
ways to maximize private resources include working
proactively with insurance companies, foundations,
community organizations and local businesses. Pay-
ment structures need to be clarified and used crea-
tively, and lawsuits need to be avoided due to the
tremendous drain of money and energy that they
cause.
A final issue raised was how the field should
move from efficacy trials to effectiveness. Efficacy
trials (also called explanatory trials) ask the question
of whether the treatment works in ideal circum-
stances; effectiveness research asks whether it works
in the real world. That is, do the essential elements of
a therapy lead to positive outcomes in the usual
practice setting, and how can these be modified
without losing the benefit found in the efficacy trials?
Efficacy trials generally use small sample sizes con-
sisting of volunteers who are defined by strict
inclusion and exclusion criteria. Treatment is carried
out by trained therapists who are supervised and
monitored using manualized programs. Outcomes are
predicted in advance and are specifically described
and limited. While attrition should be recorded in
efficacy trials, dropouts are sometimes eliminated
from analysis because the investigators’ priority is
to know if the intervention works for those who
received it.
In contrast, effectiveness studies (also called
management trials or large sample trials) are large
clinical trials with relatively few inclusion and exclu-
sion criteria. Treatment is allowed to occur as it does
in the natural world. A child might receive multiple
interventions; the usual clinic therapist would be
employed with standard clinic supervision. Outcomes
measured are very general and analyses would be
conducted on the intention to treat ‘‘last observation
carried forward’’ model. In other words, the last
observation of those who dropped out is included in
the analysis.
There are many examples in mental health of
interventions that were successful in efficacy trials but
were not useful when evaluated in the community.
Indeed, few effectiveness trials have been carried out
in children’s mental health and in autism, even
though this is seen as an essential step by some
researchers. The appropriateness of effectiveness
studies in autism at this point was a source of
discussion, without consensus, in part because there
have been only a few well-controlled efficacy trials,
and some, but not all participants felt that scientif-
ically, understanding what treatments are most ben-
eficial, when done well, must precede the question of
their effectiveness in the real world. Other partici-
pants disagreed and pointed out that, in other areas
of medicine, many treatments have gone straight
from development to dissemination.
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Recommendations
Investigators and stakeholders, including repre-
sentatives of parents’ groups, felt strongly that
recommendations from this meeting should be shared
with the public. These recommendations were
addressed to the National Institutes of Health, other
federal agencies, and private organizations involved
in funding and/or supporting (e.g. through parent
participation) research and training in autism, and
are as follows:
(1) Ongoing working groups that include inves-
tigators and federal staff should continue to
define critical gaps in the evidence base,
opportunities for moving the field forward,
and creative use of existing or new mecha-
nisms to support and facilitate advances in
the field of psychosocial intervention research
in autism. This information should be used in
considering initiatives such as requests for
applications through the National Institute
of Health and program announcements.
Ideas for ways to maximize the impact of
the information included (a) informing fed-
eral staff who provide technical assistance for
grant applications and review administration
and (b) providing background information to
peer reviewers.
(2) Inclusion of a diversity of study participants
in autism treatment research should be a
priority.
(3) (a) Study designs that would yield data that
could be pooled should be given priority.
Standard documentation including forms for
screening developed through the NIMH
Autism RUPP, records of current and past
treatments developed through the CPEA
centers and standard databases through
ISAAC (The Internet System for Assessing
Autistic Children) or individual investigators
are all available. Dissemination of practical
information concerning management of data
and research methods, as well as manualiza-
tion of interventions of wide interest should
be considered a priority for federal agencies
and foundations supporting autism treat-
ment research. (b) Minimal standards for
autism research in psychosocial treatments
were identified in terms of examiner blind-
ness, records of attrition, diagnosis of sub-
jects, manualization of treatment, measures
of maintenance and generalization, and the
independence of pre- and post-treatment
assessments from the provision of treatment.
(4) There is a need for training workshops for
autism intervention researchers in areas such
as relevant statistics, standardized methods
of diagnosis, and the development of better
outcome measures.
(5) Modification of existing measures and crea-
tion of new measures of outcome in autism
should be a high priority in order better to
document the goals for and effects of treat-
ment. Areas of special interest include mea-
sures of parent–child interaction, family
satisfaction, negative effects of treatment, and
semi-structured observations or probes for
targeted areas of change identified by parents
or teachers of individuals with autism.
(6) More controversial, particularly given the
recognition of the need for relatively large
samples to provide sufficient power to mea-
sure children by treatment interactions, was
the question of whether a very large-scale
collaborative intervention should be orga-
nized or whether the emphasis should be on
traditional investigator-initiated NIH grants
such as R01 and R21 grants through NIH.
Given evidence for strong placebo effects,
comparisons of a single treatment versus no
treatment or treatment as usual were felt to
be much less informative than comparisons
of treatments that were equally weighted in
terms of the training, belief systems, and
enthusiasm generated in investigators and in
parents. However, in developing new inter-
ventions or to address particular questions
for which they are specifically suited, treat-
ment versus no treatment designs might be
considered.
(7) Overall, it was felt that randomized clinical
trials measuring the efficacy of early and then
later interventions should be the highest, but
not the sole, priority of research evaluating
psychosocial interventions. Room for inno-
vation in treatment development and in de-
signs and statistical methods of assessing
outcomes should also be a part of any na-
tional agenda. Nevertheless, there should be
clear expectations for meeting consensually
defined standards relevant to each project.
(8) Innovative treatment designs and application
of statistical models from other areas should
be part of any national agenda. These could
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include fractional factorials, comparisons of
short-term treatments that differ from each
other on one element only, methods and
statistics to determine interactions between
psychosocial and other treatments (including
psychopharmacological), and the use of
multiple baseline techniques with random
assignment, as well as other approaches that
directly address major questions in the effects
of psycho-social interventions in ASD.
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